Nasopharyngeal CCL5 in infants with severe bronchiolitis and risk of recurrent wheezing: A multi‐center prospective cohort study.

Authors :: Hasegawa, K.
Piedra, P. A.
Bauer, C. S.
Celedón, J. C.
Mansbach, J. M.
Spergel, J. M.
Espinola, J. A.
Camargo, Jr., C. A.
The Marc‐35 Investigators
Source :: Clinical & Experimental Allergy; Aug2018, Vol. 48 Issue 8, p1063-1067, 5p, 1 Chart, 3 Graphs
Publication Year :: 2018
Abstract: The article discusses effects of nasopharyngeal CCL5 in infants depicting severe bronchiolitis with risk of recurrent wheezing. Also included are analyzing infants with respiratory syncytial virus (RSV) bronchiolitis and irregular chemokine chemoattractant causing risk of developing childhood asthma and nasopharyngeal CCL5 levels increasing risks of developing recurrent wheezing.

Subjects :: BRONCHIOLITIS
WHEEZE -- Risk factors
RESPIRATORY syncytial virus infections
ASTHMA in children
LUNG infections
DISEASE risk factors
ASTHMA risk factors

Full Text Access

Tools